Androgen receptor signaling in prostate cancer development and progression
Top Cited Papers
Open Access
- 1 January 2011
- journal article
- review article
- Published by Medknow in Journal of Carcinogenesis
- Vol. 10 (1), 20
- https://doi.org/10.4103/1477-3163.83937
Abstract
The androgen receptor (AR) signaling axis plays a critical role in the development, function and homeostasis of the prostate. The classical action of AR is to regulate gene transcriptional processes via AR nuclear translocation, binding to androgen response elements on target genes and recruitment of, or crosstalk with, transcription factors. Prostate cancer initiation and progression is also uniquely dependent on AR. Androgen deprivation therapy remains the standard of care for treatment of advanced prostate cancer. Despite an initial favorable response, almost all patients invariably progress to a more aggressive, castrate-resistant phenotype. Considerable evidence now supports the concept that development of castrate-resistant prostate cancer (CRPC) is causally related to continued transactivation of AR. Understanding the critical events and complexities of AR signaling in the progression to CRPC is essential in developing successful future therapies. This review provides a synopsis of AR structure and signaling in prostate cancer progression, with a special focus on recent findings on the role of AR in CRPC. Clinical implications of these findings and potential directions for future research are also outlined.This publication has 102 references indexed in Scilit:
- Phosphorylation and Activation of Androgen Receptor by Aurora-AOnline Journal of Public Health Informatics, 2010
- Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugsMolecular Cancer, 2009
- Loss of PTEN is associated with progression to androgen independenceThe Prostate, 2006
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Expression of NF‐κB in prostate cancer lymph node metastasesThe Prostate, 2003
- Androgen receptor gene amplification and protein expression in hormone refractory prostate cancerBritish Journal of Cancer, 2003
- Androgen Receptor Mutations in Androgen-Independent Prostate Cancer: Cancer and Leukemia Group B Study 9663Journal of Clinical Oncology, 2003
- Delineation of Two Distinct Type 1 Activation Functions in the Androgen Receptor Amino-terminal DomainPublished by Elsevier BV ,1996
- Androgen receptors in endocrine‐therapy‐resistant human prostate cancerInternational Journal of Cancer, 1991